Neudle.com: multiple sclerosis early treatment

Differential
(Click to cross reference)

abscess, intracerebral

acute disseminated encephalomyelitis

adverse drug reaction

Alzheimer's disease

Alzheimer's disease, diagnosis of

Alzheimer's disease, preclinical

amyloid beta protein

amyloid imaging

amyloid plaques

angiitis, isolated of CNS

anti MAG antibodies

antibodies to myelin basic protein

antimyelin antibodies

Barkhof MR criteria for MS

brainstem, infarction of

brainstem, lesion of

carcinoma

carcinoma of breast

carotid artery occlusion, intracranial

CAT scan

CAT scan, abnormal

CAT scan, cerebrovascular disease

CAT scan, dense artery sign

CAT scan, early changes in CVA

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, mass effect on

CAT scan, ring sign

central nervous system, infection of

central vein sign

cerebellar infarction

cerebellar lesion

cerebral arteries

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, severity

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, volume

cerebrovascular accident, work up for

cerebrovascular accident, young adult

children

Clinical Pathologic Conference(C.P.C.)

cognition

comorbidities

complications

controversies in neurology

cop 1

corneal dystrophy

corpus callosum

corpus callosum, lesion of

cyclophosphamide

degenerative diseases of CNS

dementia

dementia, diagnostic evaluation of

dementia, early detection

dementia, presenile

dementia, rapidly progressive

dementia, screening for

demyelinating disease

diabetes insipidus

diagnostic criteria

differential diagnosis

disability rating scale, neurological

disability, neurological

disease modifying agents

efficacy

encephalitis

encephalitis, viral

encephalomyelitis, postinfectious

encephalopathy, Hashimoto's

encephalopathy, metabolic

fibrinolytic agents, complications

fingolimod

florbetapir

flu-like illness

fourth ventricle, shift of

fumarate

gadolinium

gait disorder

gammaglobulin therapy, intravenous

genetic neurologic disorders

head injury

hearing loss

hearing loss, sudden, unilateral

hemiparesis

heralding manifestation

herpes simplex encephalitis

herpes virus

herpes virus infection

hippocampal atrophy

hippocampus

hydrocephalus

hydrocephalus, exvacuo

hypertension

immunomodulation

immunosuppressive agents

internal carotid artery

intracerebral hemorrhage

intravenous

iron, brain

ischemic penumbra

Jakob-Creutzfeldt disease

Kappa light chain biomarkers

liver function enzymes

lobar atrophy

Marburg's disease

McDonald criteria for MS

medulla oblongata, infarction of

memory, impairment of

mild cognitive impairment

misdiagnosis

mitoxantrone

monoclonal antibodies

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, fast

MRI, field strength

MRI, field strength, high

MRI, functional

MRI, gradient-echo

MRI, incidental finding

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, volumetry

MRS

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

natalizumab

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary intracranial

neoplasm, primary of CNS

neoplasm, primary of CNS-children

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neuropathology

neuroprotective agents

old age, neurology of

optic nerve, lesion of

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

optical coherence tomography

paramagnetic rim lesion, MR

Parkinson disease

Parkinson disease, late onset

Parkinson disease, treatment of

Parkinson disease, young onset

periventricular leukomalacia

Pittsburgh Compound B

placebo

pons, infarction of

posterior cerebral artery territory infarction

posterior fossa

posterior fossa, lesion of

practice guidelines

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

prion disease

prognosis

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudotumor

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

revascularization, surgical

sensorineural hearing loss

serologic testing

single photon emission computed tomography

slurred speech

somnambulism

spinal cord

spinal cord, enlargement

spinal cord, intramedullary cyst of

spinal cord, lesion of

spinal cord, neoplasm

spinal cord, neoplasm, infants and children

steroid

steroid therapy, CNS treatment and complications with

stroke disability scale

symmetric brain lesions

symptomatic

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

T lesion of MCA-ICA

temporal lobe, atrophy

thyroiditis

tinnitus

tissue plasminogen activator, intravenous

toxic encephalopathy

transient ischemic attack

treatment of neurologic disorder

uremia

urinary incontinence

urinary retention

ventricular enlargement

vertebral-basilar insufficiency

viral infection, reactivation

visual evoked response

West Nile fever

white matter disease

white matter disease, periventricular

Showing articles 850 to 900 of 4413 << Previous Next >>

The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999

General Neurologist and Subspecialist Care for Multiple Sclerosis, Patients' Perceptions
Neurol 53:1190-1197, Vickrey,B.G.,et al, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Neuropsychological Status in Multiple Sclerosis after Treatment with Glatiramer
Arch Neurol 56:319-324, Weinstein,A.,et al, 1999

Quantitative MRI in Patients with Clinically Isolated Syndromes Suggestive of Demyelination
Neurol 52:599-606, Sailer,M.,et al, 1999

Utilization of Unconventional Treatments by Persons with MS:Is It Alternative or Complementary?
Neurol 52:626-629, Schwartz,C.E.,et al, 1999

Multiple Sclerosis Associated with Uveitis in Two Large Clinic-Based Series
Neurol 52:179-181, Biousse,V.,et al, 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

Magnetization Transfer Imaging of Patients with Definite MS and Negative Conventional MRI
Neurol 52:845-848, Filippi,M.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis,Relation to Inflammatory Activity
Arch Neurol 56:345-351, van Walderveen,M.A.A.,et al, 1999

Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999
NEJM 340:945-953, , 1999

Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999

Quantitative MRI in CADASIL, Correlation with Disability and Cognitive Performance
Neurol 52:1361-1367, Dichgans,M.,et al, 1999

Fibromyalgia Syndrome a Decade Later
Arch Int Med 159:777-785, Goldenberg,D.L., 1999

Burden of Migraine in the United States, Disability and Economic Costs
Arch Int Med 159:813-818, Hu,X.H.,et al, 1999

Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999

Relevance of Hypointense Lesions on Fast Fluid-Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis
AJNR 20:813-820, Rovaris,M.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Brain Structure and Neurocognitive and Behavioural Function in Adolescents Who Were Born Very Preterm
Lancet 353:1653-1657, Stewart,A.L.,et al, 1999

Trigeminal Neuralgia Triggered by Auditory Stimuli in Multiple Sclerosis
Arch Neurol 56:731-733, Hartmann,M.,et al, 1999

Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998

Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998

Assessment of Motor Function After Stereotactic Pallidotomy
Neurol 50:266-270, Ondo,W.G.,et al, 1998

Extended Use of Glatiramer Acetate (Copaxone) Is Well Tol & Maint Its Clin Effect on MS Relapse Rate & Degree of Disabil
Neurol 50:701-708, Johnson,K.P.,et al, 1998

Intravenous Immunoglobulin Treatment in Multiple Sclerosis, Effect on Relapses
Neurol 50:398-402, Achiron,A.,et al, 1998

Neurologic Outcomes in Children with Post-Pump Choreoathetosis
J Pediatr 132:162-164, Holden,K.R.,et al, 1998

Interferon Treatment for Multiple Sclerosis:Autoimmune Complications May be Lethal
Neurol 50:570-571, Durelli,L.,et al, 1998

Multiple Sclerosis Associated with Chlamydia Pneumoniae Infection of the CNS
Neurol 50:571-572, Sriram,S.,et al, 1998

Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998

Large Infarcts in the Middle Cerbral Artery Territory, Etiology & Outcome Patterns
Neurol 50:341-350, Heinsius,T.,et al, 1998

Axonal Transection in the Lesions of Multiple Sclerosis
NEJM 338:278-285, 3231998., Trapp,B.D.,et al, 1998

Asympt Spinal Cord Lesions in Clin Isolated Optic Nerve, Brain Stem, & Spinal Cord Synd Suggest of Demyel
JNNP 64:353-357, O'Riordan,J.J.,et al, 1998

Effect of Steroids on Gd-Enhancing Lesions Before & During Beta Interferon 1a Trtm in Relapsing Remitting MS
Neurol 50:403-406, Gasperini,C.,et al, 1998

MR Differential Diagnosis of Normal-Pressure Hydrocephalus and Alzheimer Disease:Significance of Perihippocampal Fissures
AJNR 19:813-819, Holodny,A.I.,et al, 1998

CSF Spaces in Idiopathic Normal Pressure Hydrocephalus:Morphology and Volumetry
AJNR 19:1277-1284, 12851998., Kitagaki,H.,et al, 1998

Magnetization Transfer Changes in Normal Appearing White Matter Precede Appear of Enhancing Lesions in Pts with MS
Ann Neurol 43:809-814, Filippi,M.,et al, 1998

Near-Fatal Heat Stroke During the 1995 Heat Wave in Chicago
Ann Int Med 129:173-181, Damatte,J.E.,et al, 1998

Incidence and Significance of Neutralizing Antibodies to Interferon Beta-1a in Multiple Sclerosis
Neurol 50:1266-1272, 12061998., Rudick,R.A.,et al, 1998

Showing articles 850 to 900 of 4413 << Previous Next >>